High cost of GLP-1s drives some to seek cheaper, unregulated versions

PBS NewsHour - Science by PBS NewsHour

Despite some recent improvements, millions of Americans still face significant barriers in affording GLP-1s. At the same time, many patients have found alternative, cheaper paths to get their hands on unregulated version...View more